Immunology
-
Recall of pre-existing cross-reactive B cell memory following Omicron breakthrough infection
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
This article has 134 authors:Reviewed by ScreenIT
-
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans
This article has 24 authors:Reviewed by ScreenIT
-
Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation
This article has 18 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity
This article has 10 authors:Reviewed by ScreenIT
-
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
This article has 33 authors:Reviewed by ScreenIT
-
CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses
This article has 12 authors:Reviewed by ScreenIT
-
Fam49b dampens TCR signal strength to regulate survival of positively selected thymocytes and peripheral T cells
This article has 10 authors:This article has been curated by 1 group:Reviewed by eLife
-
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
This article has 56 authors:Reviewed by ScreenIT
-
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
This article has 25 authors:This article has been curated by 1 group: